Market Mover | Ainos Shares Soar 30% After the Company Reports Progress in Clinical Trials of Ainos Flora Testing Device

The company announced progress in the clinical trials of its Ainos Flora volatile organic compound point-of-care testing device.

moomoo NewsJun 14 09:40 ET · Movers

Ainos AIMD AI Ainos Flora Leverage; Bio-Path BPTH Phase 2 Data

BioPharmCatalystJun 14 08:25 ET

Express News | Ainos Inc - Clinical Trials for AI Nose-Powered Ainos Flora Device Moves Forward With 75Meaningful Case Results

ReutersJun 14 08:09 ET

Express News | Ainos Inc - Ainos Unveils Critical Progress in Ainos Flora Clinical Trials and Next-Gen Plans Powered by Nvidia Cuda

ReutersJun 14 08:09 ET

12 Health Care Stocks Moving In Friday's Pre-Market Session

GainersAinos (NASDAQ:AIMD) stock rose 54.8% to $1.27 during Friday's pre-market session. The market value of their outstanding shares is at $8.2 million. Longeveron (NASDAQ:LGVN) shares moved upwards

BenzingaJun 14 08:06 ET

Express News | Ainos Inc Files for Mixed Shelf of up to $200 Mln – SEC Filing

ReutersMay 31 16:40 ET